BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12353680)

  • 21. National surveillance for asthma--United States, 1980-2004.
    Moorman JE; Rudd RA; Johnson CA; King M; Minor P; Bailey C; Scalia MR; Akinbami LJ;
    MMWR Surveill Summ; 2007 Oct; 56(8):1-54. PubMed ID: 17947969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02.
    Schappert SM; Burt CW
    Vital Health Stat 13; 2006 Feb; (159):1-66. PubMed ID: 16471269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data.
    Smith ES; Fleischer AB; Feldman SR; Williford PM
    Cutis; 2002 Mar; 69(3):191-8, 201-2. PubMed ID: 11926339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Office visits to orthopedic surgeons: United States, 1995-96.
    Schappert SM
    Adv Data; 1998 Sep; (302):1-32. PubMed ID: 10662353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Top dermatologic diagnoses by age.
    Landis ET; Davis SA; Taheri A; Feldman SR
    Dermatol Online J; 2014 Apr; 20(4):22368. PubMed ID: 24746305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmelanoma skin cancer visits and procedure patterns in a nationally representative sample: national ambulatory medical care survey 1995-2007.
    Wysong A; Linos E; Hernandez-Boussard T; Arron ST; Gladstone H; Tang JY
    Dermatol Surg; 2013 Apr; 39(4):596-602. PubMed ID: 23331766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in the Cost of Managing Actinic Keratosis.
    Kirby JS; Gregory T; Liu G; Leslie DL; Miller JJ
    JAMA Dermatol; 2017 Apr; 153(4):264-269. PubMed ID: 28249074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs of Keratinocyte Carcinoma (Nonmelanoma Skin Cancer) and Actinic Keratosis Treatment in the Veterans Health Administration.
    Yoon J; Phibbs CS; Chow A; Pomerantz H; Weinstock MA
    Dermatol Surg; 2016 Sep; 42(9):1041-7. PubMed ID: 27465252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study.
    Balkrishnan R; Cayce KA; Kulkarni AS; Orsagh T; Gallagher JR; Richmond D; Feldman SR
    J Dermatolog Treat; 2006; 17(3):162-6. PubMed ID: 16854758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC; Barnetson RS; Halliday GM
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using NAMCS to characterize the urban health care safety net.
    LaCalle E; Schechter CB; McKee MD; Fletcher J
    J Health Care Poor Underserved; 2007 Feb; 18(1):152-60. PubMed ID: 17337804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of GE Centricity Electronic Medical Record database and National Ambulatory Medical Care Survey findings on the prevalence of major conditions in the United States.
    Crawford AG; Cote C; Couto J; Daskiran M; Gunnarsson C; Haas K; Haas S; Nigam SC; Schuette R; Yaskin J
    Popul Health Manag; 2010 Jun; 13(3):139-50. PubMed ID: 20568974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public.
    Halpern AC; Kopp LJ
    Int J Dermatol; 2005 Feb; 44(2):107-11. PubMed ID: 15689206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and awareness of actinic keratosis: barriers and opportunities.
    Rosen T; Lebwohl MG
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S2-9. PubMed ID: 23228302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma.
    Fuchs A; Marmur E
    Dermatol Surg; 2007 Sep; 33(9):1099-101. PubMed ID: 17760601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis and cardiovascular screening rates in the United States.
    Alamdari HS; Gustafson CJ; Davis SA; Huang W; Feldman SR
    J Drugs Dermatol; 2013 Jan; 12(1):e14-9. PubMed ID: 23377342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.